Latest Superannuation News

BCAL Diagnostics appoints Anne-Louise Arnett as CEO effective June 2026, aiming to accelerate its commercial rollout and international market entry of early cancer detection tests.

Vectus Biosystems appoints Dr Tara Speranza as CEO and CTO to accelerate development of lead fibrosis drug VB0004 with performance-linked incentives.

Arovella Therapeutics has named Dr Nicole Van Der Weerden as acting CEO following Dr Michael Baker’s departure, positioning her to steer the company through the critical phase I trial of its CAR-iNKT therapy ALA-101.

The GPT Group delivered strong operational results in Q1 2026 with near-record occupancy across retail, office, and logistics assets, alongside solid retail sales and leasing activity. The group’s $610 million oversubscribed equity raise in its Wholesale Shopping Centre Fund underpins growth plans, while FY 2026 earnings guidance is reiterated.

Carnavale Resources has appointed Humphrey Hale as Managing Director, entrusting him to lead the Kookynie Gold Project into production as the company nears completion of its bankable feasibility study.

Nuix has appointed John Ruthven as its permanent CEO and Managing Director, ending a global search and signalling leadership continuity following his interim role since November 2025.

Geopacific Resources shakes up leadership with Hamish Bohannan as new Managing Director and Rowan Johnston as Chairman, aligning the company for Woodlark’s transition from DFS to development.

Terra Metals has unveiled a significant platinum group metal sulfide system at its Southwest Prospect within the Dante Project, backed by robust assay results and a strong cash position following a recent $85 million capital raise.

AVADA Group reported a 14.9% rise in cash receipts for Q1 2026, underpinned by strong sales in Queensland and New South Wales, while completing a refinancing that improves liquidity and covenant headroom.

Focus Minerals Ltd maintained steady gold production and processing efficiency at Coolgardie during the March 2026 quarter, generating robust sales revenue and a healthy cash position.

EVE Health Group has appointed Ben Rohr as CEO, shifting Damian Wood to focus on regulatory and clinical affairs, aiming to sharpen commercial execution amid ongoing product rollouts.

Far Northern Resources has confirmed significant extensions to its Bridge Creek gold resource following Phase 2 drilling, revealing new mineralisation zones and setting a structured five-step plan for 2026 development.